SlideShare a Scribd company logo
3.RESULTS
The figure shows that decision making in this way is fragmented, compartmentalised, and doesn’t follow common
objectives. This seems to be the case whether or not structured priority setting processes are used.
We also found substantial between-country variation in priority setting at all levels across LMICs: some countries have
implemented formal processes at the micro level (e.g. Thailand), whilst others have implemented major reforms at the macro
level (e.g. Rwanda). In many other LMICs, priority setting remains informal.
We identified a number of policy options and tools which could be, or have been, used to realign decision making at the
different levels in LMICs. These fall into three main categories:
1. A consistent principle of value being used to inform decision making at all levels;
2. Strengthening decision making at the disease (or intermediate) level;
3. Collecting and monitoring data on health and economic consequences of decisions at all levels.
Building Efficient Healthcare Systems
Through Integrated Health Care Decision
Making in Low and Middle Income Countries
Grace Marsden*, Martina Garau, Adrian Towse
*presenting author; email: gmarsden@ohe.org
1. INTRODUCTION
Acknowledgements
This work was funded by Novartis. The authors would like to thank Christophe Carbonel and the project team at Novartis for their input and feedback,
and thank the global health experts for participating in interviews with us.
2. METHODS
4. CONCLUSION
• Health technology assessment (HTA) and other
tools for decision making are used around the
world to promote efficient resource allocation within
healthcare systems (HCS)
• Resource allocation decisions are made at various
levels (national level or regional level; disease level
or technology level), yet it seems that the
objectives of decision makers at the different levels
do not always align with one another
• We explore whether these inconsistencies exist in
current processes in low and middle income
countries (LMICs), and identify policy options
which could be used to improve the efficiency of
resource allocation processes in these regions.
• Three strands of literature were reviewed:
1. Current approaches for priority setting in
LMICs;
2. Health service delivery and integrated care
(including disease management programmes
(DMPs));
3. Future of healthcare systems.
• Specific case studies illustrating examples of DMPs
and healthcare system reforms implemented in
LMICs were identified.
• Interviews with a set of global health experts
were conducted to gather further information on
existing priority setting processes in LMIC and the
different levels of decision making identified in the
literature review.
Micro decision making
Decision makers: Doctors, HTA
agencies, payers
Methods: HBP, HTA, A4R, MCDA,
value of implementation
Criteria: cost effectiveness, equity
Intermediate decision making
Decision makers: Payers, Providers,
Government
Methods: guidelines, protocols,
incentive schemes
Criteria: clinical outcome improvements
Macro decision making
Decision makers: Government,
insurers
Methods: Budget allocation
Criteria: equity, affordability
Service
delivery
Interventions (medical
products, vaccines and
technologies)
Payment
schemes
Health
workforce
Improved health (level and equity)
Responsiveness
Social and financial risk protection
Improved efficiency
Configuration of
facilities
Disease and
social priorities
Financing
We discuss three key levels of decision making: macro, intermediate and micro level (see figure).
Summary of levels:
different decision
makers at different
levels do not follow
common methods or
criteria
The components of the
health system:
compartmentalised and
planned at different levels
The fragmented
components are expected
to work together to
achieve these system
objectives1
Fragmentation and misalignment between levels of decision making means that decision maker’s objectives are not
consistent, and is highly likely to lead to inefficiencies in health systems.
There are limited policy options and tools available which could be used to align the objectives of decision making throughout
governments and health services. Further research is required to develop an integrated decision making framework that
could align all levels of decision making.
Notes
1The system objectives included in the diagram are those listed in the WHO building blocks framework. Full reference: WHO, 2007. Everybody’s
business: strengthening health systems to improve health outcomes: WHO's framework for action. Geneva: World Health Organization.

More Related Content

What's hot

Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
 Are Wider Societal Effects Considered in Healthcare Decision-making? An over... Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
Office of Health Economics
 
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICAHEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
Office of Health Economics
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Office of Health Economics
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Office of Health Economics
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
Office of Health Economics
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
Kerry Sheppard
 
Value of transferability and efficiency in HTA
Value of transferability and efficiency in HTAValue of transferability and efficiency in HTA
Value of transferability and efficiency in HTA
Office of Health Economics
 
Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing
Office of Health Economics
 
Equity Adjusted QALYs? QALYs and Equity
Equity Adjusted QALYs? QALYs and EquityEquity Adjusted QALYs? QALYs and Equity
Equity Adjusted QALYs? QALYs and Equity
Kerry Sheppard
 
Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?
Office of Health Economics
 
MCDA devlin nov14
MCDA devlin nov14MCDA devlin nov14
MCDA devlin nov14
Office of Health Economics
 
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Office of Health Economics
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
Kerry Sheppard
 
Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14
Office of Health Economics
 
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
Office of Health Economics
 
Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014
Office of Health Economics
 
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Office of Health Economics
 
Establishing an Aligned View of a Modern Forward-looking HTA Process
Establishing an Aligned View of a Modern Forward-looking HTA ProcessEstablishing an Aligned View of a Modern Forward-looking HTA Process
Establishing an Aligned View of a Modern Forward-looking HTA Process
Office of Health Economics
 
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMRThe Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
Office of Health Economics
 
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Office of Health Economics
 

What's hot (20)

Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
 Are Wider Societal Effects Considered in Healthcare Decision-making? An over... Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
Are Wider Societal Effects Considered in Healthcare Decision-making? An over...
 
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICAHEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
 
Value of transferability and efficiency in HTA
Value of transferability and efficiency in HTAValue of transferability and efficiency in HTA
Value of transferability and efficiency in HTA
 
Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing Making value-based pricing a reality – the case for multi-indication pricing
Making value-based pricing a reality – the case for multi-indication pricing
 
Equity Adjusted QALYs? QALYs and Equity
Equity Adjusted QALYs? QALYs and EquityEquity Adjusted QALYs? QALYs and Equity
Equity Adjusted QALYs? QALYs and Equity
 
Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?
 
MCDA devlin nov14
MCDA devlin nov14MCDA devlin nov14
MCDA devlin nov14
 
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14Adaptive pathways intro_ispor_second_plenary_nov14
Adaptive pathways intro_ispor_second_plenary_nov14
 
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014
 
Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014Ispor workshop value-based_assess_nice_kks_nov2014
Ispor workshop value-based_assess_nice_kks_nov2014
 
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
 
Establishing an Aligned View of a Modern Forward-looking HTA Process
Establishing an Aligned View of a Modern Forward-looking HTA ProcessEstablishing an Aligned View of a Modern Forward-looking HTA Process
Establishing an Aligned View of a Modern Forward-looking HTA Process
 
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMRThe Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
The Role of HTA in Incentivising New Drugs and Vaccines to Tackle AMR
 
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
 

Viewers also liked

HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary SphincterHTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
REBRATSoficial
 
Ispor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gmIspor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gm
Office of Health Economics
 
Ispor are uk_systems_innovation_compatible_ac
Ispor are uk_systems_innovation_compatible_acIspor are uk_systems_innovation_compatible_ac
Ispor are uk_systems_innovation_compatible_ac
Office of Health Economics
 
Ispor measuring access_pon_nd
Ispor measuring access_pon_ndIspor measuring access_pon_nd
Ispor measuring access_pon_nd
Office of Health Economics
 
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
Office of Health Economics
 
Ispor do nice_decisions_affect_decisions_in_other_countries
Ispor do nice_decisions_affect_decisions_in_other_countriesIspor do nice_decisions_affect_decisions_in_other_countries
Ispor do nice_decisions_affect_decisions_in_other_countries
Office of Health Economics
 
Ispor opportunity costs_sks
Ispor opportunity costs_sksIspor opportunity costs_sks
Ispor opportunity costs_sks
Office of Health Economics
 
ISPOR poster ri lwcp 140515
ISPOR poster   ri lwcp  140515ISPOR poster   ri lwcp  140515
ISPOR poster ri lwcp 140515
Office of Health Economics
 
Devlin mcda philadelphia ispor 150515
Devlin  mcda philadelphia ispor 150515 Devlin  mcda philadelphia ispor 150515
Devlin mcda philadelphia ispor 150515
Office of Health Economics
 
ISPOR poster - direct elicitation 280415
ISPOR poster - direct elicitation 280415ISPOR poster - direct elicitation 280415
ISPOR poster - direct elicitation 280415
Office of Health Economics
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Office of Health Economics
 
A Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value setsA Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value sets
Office of Health Economics
 
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed healthAnchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
Office of Health Economics
 
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Office of Health Economics
 
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
Office of Health Economics
 
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and PostersOHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
Office of Health Economics
 
Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...
Office of Health Economics
 
A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...
Office of Health Economics
 
Can we really compare and aggregate PRO data between people and setting
Can we really compare and aggregate PRO data  between people and settingCan we really compare and aggregate PRO data  between people and setting
Can we really compare and aggregate PRO data between people and setting
Office of Health Economics
 
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
Office of Health Economics
 

Viewers also liked (20)

HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary SphincterHTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
HTAi 2015 - poster 238 - Efficiency of the Artificial Urinary Sphincter
 
Ispor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gmIspor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gm
 
Ispor are uk_systems_innovation_compatible_ac
Ispor are uk_systems_innovation_compatible_acIspor are uk_systems_innovation_compatible_ac
Ispor are uk_systems_innovation_compatible_ac
 
Ispor measuring access_pon_nd
Ispor measuring access_pon_ndIspor measuring access_pon_nd
Ispor measuring access_pon_nd
 
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
Reflections on Implementing Value-based Assessment in the UK -- Towse at HESG
 
Ispor do nice_decisions_affect_decisions_in_other_countries
Ispor do nice_decisions_affect_decisions_in_other_countriesIspor do nice_decisions_affect_decisions_in_other_countries
Ispor do nice_decisions_affect_decisions_in_other_countries
 
Ispor opportunity costs_sks
Ispor opportunity costs_sksIspor opportunity costs_sks
Ispor opportunity costs_sks
 
ISPOR poster ri lwcp 140515
ISPOR poster   ri lwcp  140515ISPOR poster   ri lwcp  140515
ISPOR poster ri lwcp 140515
 
Devlin mcda philadelphia ispor 150515
Devlin  mcda philadelphia ispor 150515 Devlin  mcda philadelphia ispor 150515
Devlin mcda philadelphia ispor 150515
 
ISPOR poster - direct elicitation 280415
ISPOR poster - direct elicitation 280415ISPOR poster - direct elicitation 280415
ISPOR poster - direct elicitation 280415
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
 
A Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value setsA Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value sets
 
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed healthAnchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
 
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
 
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
 
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and PostersOHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
 
Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...
 
A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...
 
Can we really compare and aggregate PRO data between people and setting
Can we really compare and aggregate PRO data  between people and settingCan we really compare and aggregate PRO data  between people and setting
Can we really compare and aggregate PRO data between people and setting
 
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
Ispor poster appropriate_comparator_health_state_in_tto_studies_kks_oct2014
 

Similar to HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries

Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
IDS
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesCochrane.Collaboration
 
Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...
ReBUILD for Resilience
 
Juanitas Final April 29 2007
Juanitas Final April 29 2007Juanitas Final April 29 2007
Juanitas Final April 29 2007primary
 
at-mod-3-info.pptx
at-mod-3-info.pptxat-mod-3-info.pptx
at-mod-3-info.pptx
AgungBudiLaksono7
 
Allocating resources for healthcare.pptx
Allocating resources for healthcare.pptxAllocating resources for healthcare.pptx
Allocating resources for healthcare.pptx
KeirelEdrin
 
Evaluation of health services
Evaluation of health servicesEvaluation of health services
Evaluation of health services
kavita yadav
 
Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)
MarksMan Healthcare Communications
 
NHC Essential Health Benefits Recommendations
NHC Essential Health Benefits RecommendationsNHC Essential Health Benefits Recommendations
NHC Essential Health Benefits Recommendations
National Health Council
 
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015Marie Smith, PharmD
 
Quality improvement and patient safety in anesthesia
Quality improvement and patient safety in anesthesiaQuality improvement and patient safety in anesthesia
Quality improvement and patient safety in anesthesia
Dr. Ravikiran H M Gowda
 
Health system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 updateHealth system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 update
ReBUILD for Resilience
 
9054 Cardiff Student Poster final .6.08b
9054 Cardiff Student Poster final .6.08b9054 Cardiff Student Poster final .6.08b
9054 Cardiff Student Poster final .6.08bNicola Allen
 
HCM 3305, Community Health 1 Course Learning Outcom.docx
 HCM 3305, Community Health 1 Course Learning Outcom.docx HCM 3305, Community Health 1 Course Learning Outcom.docx
HCM 3305, Community Health 1 Course Learning Outcom.docx
aryan532920
 
Beyond Scaling Up: Change and complex health systems
Beyond Scaling Up: Change and complex health systemsBeyond Scaling Up: Change and complex health systems
Beyond Scaling Up: Change and complex health systems
IDS
 
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomesEvaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
cheweb1
 
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Office of Health Economics
 
E health system design
E health system designE health system design
E health system design
Tanjarul Islam Mishu
 

Similar to HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries (20)

Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence Syntheses
 
Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...
 
Juanitas Final April 29 2007
Juanitas Final April 29 2007Juanitas Final April 29 2007
Juanitas Final April 29 2007
 
Toolkit Outline
Toolkit OutlineToolkit Outline
Toolkit Outline
 
at-mod-3-info.pptx
at-mod-3-info.pptxat-mod-3-info.pptx
at-mod-3-info.pptx
 
Allocating resources for healthcare.pptx
Allocating resources for healthcare.pptxAllocating resources for healthcare.pptx
Allocating resources for healthcare.pptx
 
Evaluation of health services
Evaluation of health servicesEvaluation of health services
Evaluation of health services
 
Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)
 
NHC Essential Health Benefits Recommendations
NHC Essential Health Benefits RecommendationsNHC Essential Health Benefits Recommendations
NHC Essential Health Benefits Recommendations
 
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015
FINAL MSmith_ Medn Measures that Matter_ AJPB_Jan-Feb 2015
 
Quality improvement and patient safety in anesthesia
Quality improvement and patient safety in anesthesiaQuality improvement and patient safety in anesthesia
Quality improvement and patient safety in anesthesia
 
Health system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 updateHealth system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 update
 
9054 Cardiff Student Poster final .6.08b
9054 Cardiff Student Poster final .6.08b9054 Cardiff Student Poster final .6.08b
9054 Cardiff Student Poster final .6.08b
 
HCM 3305, Community Health 1 Course Learning Outcom.docx
 HCM 3305, Community Health 1 Course Learning Outcom.docx HCM 3305, Community Health 1 Course Learning Outcom.docx
HCM 3305, Community Health 1 Course Learning Outcom.docx
 
Beyond Scaling Up: Change and complex health systems
Beyond Scaling Up: Change and complex health systemsBeyond Scaling Up: Change and complex health systems
Beyond Scaling Up: Change and complex health systems
 
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomesEvaluating the impact of HTA and ‘better decision-making’ on health outcomes
Evaluating the impact of HTA and ‘better decision-making’ on health outcomes
 
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
 
E health system design
E health system designE health system design
E health system design
 
WhitePaper_VBP_FINAL
WhitePaper_VBP_FINALWhitePaper_VBP_FINAL
WhitePaper_VBP_FINAL
 

More from Office of Health Economics

Annual lecture
Annual lecture Annual lecture
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
Office of Health Economics
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
Office of Health Economics
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
Office of Health Economics
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
Office of Health Economics
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
Office of Health Economics
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
Office of Health Economics
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
Office of Health Economics
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
Office of Health Economics
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Office of Health Economics
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
Office of Health Economics
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
Office of Health Economics
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
Office of Health Economics
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
Office of Health Economics
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Office of Health Economics
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
Office of Health Economics
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Office of Health Economics
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
Office of Health Economics
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
Office of Health Economics
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
Office of Health Economics
 

More from Office of Health Economics (20)

Annual lecture
Annual lecture Annual lecture
Annual lecture
 
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
 

Recently uploaded

Obesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditionsObesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditions
Faculty of Medicine And Health Sciences
 
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
OECD Directorate for Financial and Enterprise Affairs
 
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Sebastiano Panichella
 
Getting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control TowerGetting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control Tower
Vladimir Samoylov
 
International Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software TestingInternational Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software Testing
Sebastiano Panichella
 
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Sebastiano Panichella
 
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdfBonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
khadija278284
 
Acorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutesAcorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutes
IP ServerOne
 
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Orkestra
 
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXOBitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Matjaž Lipuš
 
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
0x01 - Newton's Third Law:  Static vs. Dynamic Abusers0x01 - Newton's Third Law:  Static vs. Dynamic Abusers
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
OWASP Beja
 
Eureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 PresentationEureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 Presentation
Access Innovations, Inc.
 
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptxsomanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
Howard Spence
 

Recently uploaded (13)

Obesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditionsObesity causes and management and associated medical conditions
Obesity causes and management and associated medical conditions
 
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
Competition and Regulation in Professional Services – KLEINER – June 2024 OEC...
 
Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...Announcement of 18th IEEE International Conference on Software Testing, Verif...
Announcement of 18th IEEE International Conference on Software Testing, Verif...
 
Getting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control TowerGetting started with Amazon Bedrock Studio and Control Tower
Getting started with Amazon Bedrock Studio and Control Tower
 
International Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software TestingInternational Workshop on Artificial Intelligence in Software Testing
International Workshop on Artificial Intelligence in Software Testing
 
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...Doctoral Symposium at the 17th IEEE International Conference on Software Test...
Doctoral Symposium at the 17th IEEE International Conference on Software Test...
 
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdfBonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
Bonzo subscription_hjjjjjjjj5hhhhhhh_2024.pdf
 
Acorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutesAcorn Recovery: Restore IT infra within minutes
Acorn Recovery: Restore IT infra within minutes
 
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...
 
Bitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXOBitcoin Lightning wallet and tic-tac-toe game XOXO
Bitcoin Lightning wallet and tic-tac-toe game XOXO
 
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
0x01 - Newton's Third Law:  Static vs. Dynamic Abusers0x01 - Newton's Third Law:  Static vs. Dynamic Abusers
0x01 - Newton's Third Law: Static vs. Dynamic Abusers
 
Eureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 PresentationEureka, I found it! - Special Libraries Association 2021 Presentation
Eureka, I found it! - Special Libraries Association 2021 Presentation
 
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptxsomanykidsbutsofewfathers-140705000023-phpapp02.pptx
somanykidsbutsofewfathers-140705000023-phpapp02.pptx
 

HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries

  • 1. 3.RESULTS The figure shows that decision making in this way is fragmented, compartmentalised, and doesn’t follow common objectives. This seems to be the case whether or not structured priority setting processes are used. We also found substantial between-country variation in priority setting at all levels across LMICs: some countries have implemented formal processes at the micro level (e.g. Thailand), whilst others have implemented major reforms at the macro level (e.g. Rwanda). In many other LMICs, priority setting remains informal. We identified a number of policy options and tools which could be, or have been, used to realign decision making at the different levels in LMICs. These fall into three main categories: 1. A consistent principle of value being used to inform decision making at all levels; 2. Strengthening decision making at the disease (or intermediate) level; 3. Collecting and monitoring data on health and economic consequences of decisions at all levels. Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries Grace Marsden*, Martina Garau, Adrian Towse *presenting author; email: gmarsden@ohe.org 1. INTRODUCTION Acknowledgements This work was funded by Novartis. The authors would like to thank Christophe Carbonel and the project team at Novartis for their input and feedback, and thank the global health experts for participating in interviews with us. 2. METHODS 4. CONCLUSION • Health technology assessment (HTA) and other tools for decision making are used around the world to promote efficient resource allocation within healthcare systems (HCS) • Resource allocation decisions are made at various levels (national level or regional level; disease level or technology level), yet it seems that the objectives of decision makers at the different levels do not always align with one another • We explore whether these inconsistencies exist in current processes in low and middle income countries (LMICs), and identify policy options which could be used to improve the efficiency of resource allocation processes in these regions. • Three strands of literature were reviewed: 1. Current approaches for priority setting in LMICs; 2. Health service delivery and integrated care (including disease management programmes (DMPs)); 3. Future of healthcare systems. • Specific case studies illustrating examples of DMPs and healthcare system reforms implemented in LMICs were identified. • Interviews with a set of global health experts were conducted to gather further information on existing priority setting processes in LMIC and the different levels of decision making identified in the literature review. Micro decision making Decision makers: Doctors, HTA agencies, payers Methods: HBP, HTA, A4R, MCDA, value of implementation Criteria: cost effectiveness, equity Intermediate decision making Decision makers: Payers, Providers, Government Methods: guidelines, protocols, incentive schemes Criteria: clinical outcome improvements Macro decision making Decision makers: Government, insurers Methods: Budget allocation Criteria: equity, affordability Service delivery Interventions (medical products, vaccines and technologies) Payment schemes Health workforce Improved health (level and equity) Responsiveness Social and financial risk protection Improved efficiency Configuration of facilities Disease and social priorities Financing We discuss three key levels of decision making: macro, intermediate and micro level (see figure). Summary of levels: different decision makers at different levels do not follow common methods or criteria The components of the health system: compartmentalised and planned at different levels The fragmented components are expected to work together to achieve these system objectives1 Fragmentation and misalignment between levels of decision making means that decision maker’s objectives are not consistent, and is highly likely to lead to inefficiencies in health systems. There are limited policy options and tools available which could be used to align the objectives of decision making throughout governments and health services. Further research is required to develop an integrated decision making framework that could align all levels of decision making. Notes 1The system objectives included in the diagram are those listed in the WHO building blocks framework. Full reference: WHO, 2007. Everybody’s business: strengthening health systems to improve health outcomes: WHO's framework for action. Geneva: World Health Organization.